Close Menu

data integration

The integration on the Microsoft Azure cloud is helping Kaiser make its vast genomics dataset available to a wider pool of researchers.

Syapse continues to help the FDA Oncology Center of Excellence incorporate real-world data into the regulatory decision-making process.

BlackRock, the world's largest investment manager, led the round, joined by new investors Deerfield Management and Moore Strategic Ventures as well as existing investors.

Formerly the data analytics division of CTCA, Vidence is supporting an immuno-oncology trial for BMS as it looks to grow its network of hospital partners.

Duality will apply homomorphic encryption to data from multiple sources to train machine learning while safeguarding the privacy of individual patients.

The company hopes to improve its Dragen analysis platform with data compression technology from Enancio and data management capabilities from BlueBee.

The software tool, currently in development, is set to be introduced next year and could also find application in other indications such as cancer.

The startup has exclusively licensed an integration engine from the University of Miami to augment its VIPER platform and improve trial recruitment specifically in precision oncology.

Working with clinical decision support vendor ActX, the suburban Chicago health system has seen strong demand for PGx and genetically informed preventive care.

In Phase 2 pilots, four healthcare organizations helped HL7 refine its FHIR Genomics specification but  uncovered many remaining hurdles to true interoperability.

Pages

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.